Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2025-12-25 @ 12:49 PM
NCT ID: NCT00336895
Description: The protocol specified adverse events including bone marrow suppression, incidence of CMV infection and incidence of acute cellular rejection.
Frequency Threshold: 0
Time Frame: 0-12 weeks
Study: NCT00336895
Study Brief: Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Liver Transplant Subjects All subjects in this study will receive Myfortic 360mg or 720 mg BID for 90 days. Myfortic: Myfortic 360mg or 720 mg BID for 90 days. None None 0 30 0 30 View
Serious Events(If Any):
Other Events(If Any):